HAEMONETICS CORPORATION financials

  1. Home
  2. Financials
  3. HAE
HAE CIK 0000313143

Source: EDGAR filings · Built 2026-06-02T03:11:14Z

Key metrics by reporting period

Up to six most-recent periods side-by-side. Rows are the curated key lines — revenue, margins, cash, debt, equity, cash-flow totals, plus the derived and valuation metrics we compute on top. For every tag a filer reported in one period, use the single-filing drilldown below.

Derived Metrics

Concept FY 2026FY 2025FY 2024FY 2023FY 2022FY 2021
Free Cash Flow 260.44M 142.45M 143.63M 81.73M 75.75M 71.77M
EBITDA 268.45M 337.40M 262.10M 249.34M 178.50M 174.03M
Working Capital 552.28M 356.86M 468.52M 517.91M 313.76M 440.05M
Net Debt 1.04B 976.59M 695.08M 544.49M 576.99M 585.97M
Gross Margin 59.04% 55.04% 52.83% 52.63% 50.90% 45.70%
Operating Margin 11.75% 16.30% 12.60% 13.35% 8.13% 10.31%
Net Margin 7.29% 12.32% 8.98% 9.87% 4.37% 9.13%
Return on Equity (ROE) 12.22% 20.43% 12.25% 14.11% 5.79% 10.86%
Return on Assets (ROA) 4.06% 6.84% 5.35% 5.96% 2.33% 4.37%
Current Ratio 2.95× 1.62× 2.56× 3.06× 1.71× 2.74×
Debt-to-Equity 1.62× 1.56× 0.91× 1.01× 1.12× 1.06×
Effective Tax Rate 24.00% 20.93% 22.59% 18.39% 31.83% -8.99%
Cash Conversion Ratio 3.01× 1.08× 1.55× 2.37× 3.97× 1.37×
Accruals Ratio -0.08× -0.01× -0.03× -0.08× -0.07× -0.02×
SBC % of Revenue 2.54% 2.18% 2.16% 2.19% 2.45% 2.93%
CapEx Coverage 8.95× 4.63× 4.77× 1.43× 1.78× 2.94×
Free Cash Flow Per Share $5.50 $2.81 $2.79 $1.59 $1.48 $1.40

Valuation Metrics

Concept FY 2026FY 2025FY 2024FY 2023FY 2022FY 2021
P/E Trailing (Diluted) 26.36× 19.09× 37.27× 36.94× 76.01× 72.28×
P/FCF 9.83× 22.50× 30.54× 52.06× 43.28× 80.08×
FCF Yield 10.18% 4.44% 3.27% 1.92% 2.31% 1.25%
EV / EBITDA 13.00× 11.92× 19.19× 18.93× 21.52× 36.12×
P/S 1.83× 2.24× 3.31× 3.57× 3.29× 6.55×
P/B 3.07× 3.71× 4.52× 5.10× 4.36× 7.79×

Income Statement

Concept FY 2026FY 2025FY 2024FY 2023FY 2022FY 2021
Revenue from Contract with Customer, Excluding Assessed Tax 1.33B 1.36B 1.31B 1.17B 993.20M —
Cost of Goods and Services Sold 546.44M 611.87M 617.51M 553.56M 487.69M 472.63M
Gross Profit 787.59M 748.96M 691.55M 615.10M 505.50M 397.84M
Research and Development Expense 59.77M 62.72M 54.44M 50.13M 46.80M 32.86M
Selling, General and Administrative Expense 442.42M 436.79M 429.78M 376.68M 340.14M 275.22M
Operating Expenses 630.85M 527.14M 526.66M 459.06M 424.75M 308.09M
Operating Income (Loss) 156.73M 221.82M 164.88M 156.03M 80.75M 89.75M
Income Tax Expense (Benefit) 30.72M 44.39M 34.31M 26.00M 20.25M -6.56M
Net Income (Loss) Attributable to Parent 97.31M 167.68M 117.56M 115.40M 43.38M 79.47M
Earnings Per Share, Basic $2.06 $3.33 $2.32 $2.27 $0.85 $1.57
Weighted Average Number of Shares Outstanding, Basic 47.18M 50.33M 50.71M 50.78M 51.05M 50.69M
Earnings Per Share, Diluted $2.05 $3.31 $2.29 $2.24 $0.84 $1.55
Weighted Average Number of Shares Outstanding, Diluted 47.35M 50.73M 51.40M 51.42M 51.35M 51.29M

Balance Sheet

Concept FY 2026FY 2025FY 2024FY 2023FY 2022FY 2021
Cash and Cash Equivalents, at Carrying Value 245.44M 306.76M 178.80M 284.47M 259.50M 192.31M
Assets, Current 834.88M 934.98M 768.90M 769.72M 756.03M 693.55M
Assets 2.40B 2.45B 2.20B 1.93B 1.86B 1.82B
Long-term Debt 1.24B 1.22B — — — —
Liabilities, Current 282.60M 578.11M 300.38M 251.82M 442.27M 253.50M
Long-term Debt, Excluding Current Maturities 1.22B 921.23M 797.56M 754.10M 559.44M 690.59M
Stockholders' Equity Attributable to Parent 796.32M 820.84M 959.96M 818.00M 749.42M 731.67M
Common Stock, Shares, Outstanding 45.25M 48.22M 50.79M 50.45M 51.12M 50.87M

Cash Flow Statement

Concept FY 2026FY 2025FY 2024FY 2023FY 2022FY 2021
Net Cash Provided by (Used in) Operating Activities 293.22M 181.72M 181.75M 273.06M 172.26M 108.81M
Payments to Acquire Property, Plant, and Equipment 32.78M 39.28M 38.13M 191.33M 96.51M 37.04M
Net Cash Provided by (Used in) Investing Activities -179.55M -161.90M -322.39M -143.79M -86.34M -425.44M
Payments for Repurchase of Common Stock 175.00M 225.00M 0 75.00M 0 0
Net Cash Provided by (Used in) Financing Activities -178.46M 108.82M 38.16M -100.36M -15.75M 367.45M

Raw XBRL tagging for a single filing

Every us-gaap and custom concept the filer tagged for one fiscal period, grouped by statement. Start here when a number in the trend table above surprises you and you want to see the exact tag behind it. Derived and valuation rows are omitted here because they already appear in the trend table.

Most recent filing shown by default.

Compare filings side-by-side

Diff any two filings with deltas and added / removed tags.

Immaterial rows are USD line items under 1% of the period's revenue — the noise floor below which a single tag rarely moves the investment thesis. Revenue is read from the filer's top-line concept (Revenues / RevenueFromContractWithCustomerExcludingAssessedTax, with a fallback chain). Non-USD rows, rows without a numeric value, and every row on a filing with no identifiable revenue anchor stay visible. Flip the switch off to see every tag the filer reported for the period.

Loading filing details…

Methodology

All facts on this page come straight from SEC EDGAR XBRL company-facts filings (HAE CIK 0000313143), grouped by financial statement using FASB's base us-gaap presentation taxonomy. Filers may re-parent concepts onto different statements in their own extension taxonomy, so a handful of rows can show up under a different statement than on the actual 10-K / 10-Q; custom concepts and any we couldn't map fall into Other. Hover a cell to see the fully-qualified concept name and the filer's description.

For the full methodology — statement grouping, the Other bucket, derived metrics, and fact tooltips — see the methodology reference for the statement grouping, the "Other" bucket, derived metrics, and fact tooltips.

Related tickers

NDSN

NORDSON CORPORATION

VNT

Vontier Corporation

DORM

Dorman Products, Inc.